Latest Industry Insights
Industry Insight
Moving Past Paper: Realizing the Potential of ELNs
Electronic Laboratory Notebooks are becoming more popular as labs embrace digitization. ELN provider Biodata’s flagship offering, Labguru, has over 30,000 users worldwide. We caught up with Steve Yemm, recently appointed CEO of BioData, to ask him about the advantages of ELNs and the challenges they face in a digital market.
Industry Insight
Say Hello to Regenerative Medicine and Goodbye to Back Pain
Degenerative disc diseases are debilitating, and treatment options are lacking. Three leaders from Discgenics explain how they are harnessing the restorative potential of cells native to the intervertebral disc to alleviate lower back pain.
Industry Insight
Tackling Antibiotic-resistance: Nitric Oxide-based Treatments for Respiratory Diseases
The failure of conventional antibiotics to treat numerous antibiotic-resistant infections necessitates the development of new agents – as a natural anti-microbial nitric oxide holds particular promise.
Industry Insight
In Vitro Systems and Inhalation Toxicology
In early July, experts from around the world met in Nice, France, to share and discuss the latest innovations and research in the context of human lung in vitro models. This blog highlights some of the topics covered during the event.
Industry Insight
Going with the Flow
This month we sat down with Dr Omar Jina, Chief Commercial Officer at Syrris Ltd., to discuss flow chemistry, its applications and the push to raise awareness of this transformative technology.
Industry Insight
Treating Diseases Associated with Pathogenic Proteins Expressed by Human Endogenous Retroviruses
We recently spoke to Dr. Hervé Perron, HDR, Chief Scientific Officer at GeNeuro to learn about their progress developing new treatments for neurological and autoimmune diseases associated with pathogenic proteins expressed by human endogenous retroviruses (HERVs).
Industry Insight
A Move Towards Precise Management of Bacterial Infections
Following the recent FDA approval of a procalcitonin assay, we spoke with a representative from Fujirebio Diagnostics, Inc. to learn how measuring this important biomarker will improve the healthcare landscape.
Industry Insight
The Digital Solutions Accelerating Scientific Discovery
Science advances at a rapid pace, and supporting technologies and infrastructures have to adapt accordingly. One of the latest evolutions in technology is the shift from traditional software and hardware tools to newer cloud-based services. In this blog, Thermo Fisher Scientific's Karen Velardi looks at, we look at the different cloud services that are changing the way modern research is done.
Industry Insight
More Tools and More Time: An Easier Future for Bioinformaticians?
In the second of a two-part blog series, we talk with Genestack CEO Misha Kapushesky on the developments in Bioinformatics that he’s most excited about, and the latest modular additions to Genestack's bioinformatics platform.
Industry Insight
Supporting the Development of Regenerative Medicines
Regenerative medicine is a branch of translational research which focuses on methods to regrow, repair or replace human cells, tissues or organs. We recently spoke with Michael May, President & CEO of CCRM, an organization supporting the development of regenerative medicines and associated technologies to learn more about their latest projects and collaborations.
Advertisement